BACKGROUND: Little is known about symptom burden and palliative care needs of breathless patients with advanced cancer and chronic obstructive pulmonary disease (COPD). OBJECTIVES: We aimed to describe and compare symptoms and needs in these two groups in relation to survival. METHODS: Cross-sectional study of breathless patients with COPD III/IV or advanced cancer. Data were collected in an interview using the Memorial Symptom Assessment Scale short form (MSAS-SF), the modified Borg Scale, the Hospital Anxiety and Depression Scale, and the Palliative Care Outcome Scale (POS). Follow-up information was collected on survival. RESULTS: Forty-nine patients with cancer and 60 patients with COPD were recruited. Both groups had similar demographics and a similar high symptom burden: median number of 14 symptoms; most prevalent symptoms in both groups besides breathlessness were drowsiness, lack of energy, cough; median global symptom distress on MSAS-Global Distress Index MSAS-GDI 1.6 in cancer and 1.4 in COPD. HADS depression scores were higher than HADS anxiety scores. Palliative care needs were also similar in both groups. Median survival was 107 days in patients with cancer and 589 days in patients with COPD. CONCLUSIONS: Symptom burden and palliative care needs of breathless patients with severe COPD are considerable and as high as among patients with advanced primary and secondary lung cancer although patients with COPD have a longer survival.
BACKGROUND: Little is known about symptom burden and palliative care needs of breathlesspatients with advanced cancer and chronic obstructive pulmonary disease (COPD). OBJECTIVES: We aimed to describe and compare symptoms and needs in these two groups in relation to survival. METHODS: Cross-sectional study of breathlesspatients with COPD III/IV or advanced cancer. Data were collected in an interview using the Memorial Symptom Assessment Scale short form (MSAS-SF), the modified Borg Scale, the Hospital Anxiety and Depression Scale, and the Palliative Care Outcome Scale (POS). Follow-up information was collected on survival. RESULTS: Forty-nine patients with cancer and 60 patients with COPD were recruited. Both groups had similar demographics and a similar high symptom burden: median number of 14 symptoms; most prevalent symptoms in both groups besides breathlessness were drowsiness, lack of energy, cough; median global symptom distress on MSAS-Global Distress Index MSAS-GDI 1.6 in cancer and 1.4 in COPD. HADS depression scores were higher than HADS anxiety scores. Palliative care needs were also similar in both groups. Median survival was 107 days in patients with cancer and 589 days in patients with COPD. CONCLUSIONS: Symptom burden and palliative care needs of breathlesspatients with severe COPD are considerable and as high as among patients with advanced primary and secondary lung cancer although patients with COPD have a longer survival.
Authors: Matthias Seibl-Leven; Christian von Reeken; Roland Goldbrunner; Stefan Grau; Maximilian Ingolf Ruge; Norbert Galldiks; Veronika Dunkl; Martin Kocher; Raymond Voltz; Heidrun Golla Journal: J Neurooncol Date: 2018-02-20 Impact factor: 4.130
Authors: Michaela Herzog; Josef Sucec; Ilse Van Diest; Omer Van den Bergh; Cecile Chenivesse; Paul Davenport; Thomas Similowski; Andreas von Leupoldt Journal: Eur Respir J Date: 2018-04-04 Impact factor: 16.671